Boosting sarcoma cell death

October 5, 2017 by Leigh Macmillan, Vanderbilt University

Ewing sarcomas – rare, aggressive childhood cancers – are derived from mesenchymal cells in bone and soft tissues, and children with metastatic disease have poor survival.

In a search for new therapeutic options for Ewing sarcoma, Dai Chung, M.D., and colleagues tested a compound previously identified at Vanderbilt, ML327, that induces the expression of the E-cadherin. E-cadherin, a hallmark of , is often lost as cancer cells become invasive. Its re-expression in epithelial cancers blocks cell invasiveness.

Now, the investigators have demonstrated in Ewing sarcoma cells that ML327 increases E-cadherin and alters the expression of other proteins, consistent with a mesenchymal-to-epithelial transition in the cells. ML327 also increased cell death, and had additive effects with a cell death-inducing ligand called TRAIL that has been tested for Ewing sarcoma.

The findings, reported in the Sept. 16 issue of Biochemical and Biophysical Research Communications, support further study of ML327, both alone and in combination with TRAIL-based strategies, in the treatment of sarcomas.

Explore further: Two agents deliver knockout punches to Ewing sarcoma

More information: Eric J. Rellinger et al. ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand, Biochemical and Biophysical Research Communications (2017). DOI: 10.1016/j.bbrc.2017.07.050

Related Stories

Two agents deliver knockout punches to Ewing sarcoma

October 3, 2017
When combined with an already FDA-approved chemotherapy, a novel agent developed by researchers at Georgetown Lombardi Comprehensive Cancer Center, appears to halt the ability of Ewing sarcoma to grow and progress.

A noncoding RNA promotes pediatric bone cancer

November 17, 2014
Ewing sarcoma is a cancer of bone or its surrounding soft tissue that primarily affects children and young adults. A hallmark of Ewing sarcoma is a translocation event that results in the fusion of an RNA binding protein, ...

A new paradigm for treating transcription factor-driven cancers

September 18, 2017
In the current issue of Proceedings of the National Academy of Sciences, researchers from Nationwide Children's Hospital describe a new paradigm for treating transcription factor-driven cancers. The study focuses on Ewing ...

'Jumonji' protein key to Ewing's sarcoma rampage

March 24, 2017
By the time Ewing's Sarcoma is diagnosed, primarily in teens and young adults, it has often spread from its primary site to other parts of the body, making it difficult to treat. A University of Colorado Cancer Center study ...

New potential therapeutic strategy against a very aggressive infant bone cancer

January 29, 2015
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL), led by Oscar Martínez Tirado participated in an international study which suggests inhibition of Sirtuin1 (SIRT1) protein as a future treatment option ...

Serendipity leads to discovery of adult cancer genes in young-adult Ewing Sarcoma

February 3, 2015
A University of Colorado Cancer Center study published in the journal PLoS One finds alterations in expression of genes PIK3R3 and PTEN, more commonly observed in adult tumors, in the rare, young-adult bone cancer Ewing Sarcoma, ...

Recommended for you

Breast cancer fuelled by mysterious Yin Yang protein

July 23, 2018
Scientists have unveiled clues about a mysterious molecule called Yin Yang1—and revealed it may fuel tumour growth in breast cancer.

Daily low-dose aspirin may be weapon against ovarian cancer

July 20, 2018
(HealthDay)— One low-dose aspirin a day could help women avoid ovarian cancer or boost their survival should it develop, two new studies suggest.

Discovery of kidney cancer driver could lead to new treatment strategy

July 19, 2018
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change ...

High fruit and vegetable consumption may reduce risk of breast cancer, especially aggressive tumors

July 19, 2018
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers ...

Sunscreen reduces melanoma risk by 40 per cent in young people

July 19, 2018
A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely ...

Analysis of prostate tumors reveals clues to cancer's aggressiveness

July 19, 2018
Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. The study lays the foundation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.